# A Study to Determine the Safety and Efficacy of TG-C in Subjects with Symptomatic Early Hip Osteoarthritis

> **NCT05276011** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Kolon TissueGene, Inc.** · enrollment: 255 (estimated)

## Conditions studied

- Degenerative Osteoarthritis

## Interventions

- **BIOLOGICAL:** TG-C
- **BIOLOGICAL:** Placebo Control

## Key facts

- **NCT ID:** NCT05276011
- **Lead sponsor:** Kolon TissueGene, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 255 (ESTIMATED)
- **Last updated:** 2024-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05276011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05276011, "A Study to Determine the Safety and Efficacy of TG-C in Subjects with Symptomatic Early Hip Osteoarthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05276011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*